Skip to content

Gut Hormones and Bone Remodeling in Humans (KS-2)

Investigation of GLP-2 Mechanism of Action (KS-2)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03573934
Acronym
KS-2
Enrollment
10
Registered
2018-06-29
Start date
2017-09-15
Completion date
2018-03-15
Last updated
2020-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Effects of GLP-2 and GIP on bone remodeling in healthy young men.

Detailed description

We will investigate acute effects of GLP-2 and GIP on bone remodeling in healthy young men.

Interventions

GLP-2+GIP

OTHERPlacebo

Placebo

OTHERGLP-2

GLP-2

OTHERGIP

GIP

Sponsors

Hvidovre University Hospital
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Age between 20 and 40 years old Caucasian Healthy BMI between 18.5 and 24.9 kg/m2.

Exclusion criteria

Chronic disease Smoking Medication Weight change more than 3 kg whitin the last 3 months Overweight surgery Intestinal surgery Hgb\<8,0 mmol/L Decreased renal function.

Design outcomes

Primary

MeasureTime frameDescription
Bone resorptionFrom -10 minutes to 240 minutes.C-terminal telopeptide (CTX) is a marker of bone resorption. Measured in serum.
Bone formationFrom -10 minutes to 240 minutes.P1NP is a marker of bone formation. Measured in serum.

Secondary

MeasureTime frameDescription
CalciumFrom -10 minutes to 240 minutes.Measured in serum.
GIPFrom -10 minutes to 240 minutes.Intact and total GIP.
GLP-2From -10 minutes to 240 minutes.Intact GLP-2
InsulinFrom -10 minutes to 240 minutes.Measured in serum.
C-peptideFrom -10 minutes to 240 minutes.Measured in serum.
SclerostinFrom -10 minutes to 240 minutes.Bone marker.
GlucoseFrom -10 minutes to 240 minutes.Measured in serum.
Parathyroid hormoneFrom -10 minutes to 240 minutes.PTH is a bone marker

Other

MeasureTime frameDescription
Heart rateFrom -10 minutes to 240 minutes.Before blood sampling
Blood pressureFrom -10 minutes to 240 minutes.Before blood sampling

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026